Today, Monday, August 10, they start testing the vaccine that Pfizer makes in conjunction with the German company Biontech, in the first volunteers of the Hospital Militar Central.
That way, the third phase of testing of the COVID-19 vaccine has begun in Brazil together with the United States and Brazil.
The vaccine is based on messenger RNA technology, which carries DNA instructions for cells in the human body to produce certain protective proteins. He started his tests in Germany in late April and in the United States in early May.
“From today we start to work together. The Argentine Army, with the Military Hospital, will provide logistical support and cooperation so that researchers can develop this important test for the coronavirus vaccine. We are very happy and happy to start this stage ”, said Maldonado during the event that took place on the premises of the medical center he runs.
The Central Military Hospital is a highly complex health center with 130 years. It has more than 90 services and is also an important training center for professionals in different specialties.
According to the authorities, all participants in these tests, military and civilian, volunteered. Therefore, and respecting good clinical practices in the implementation of medical research, your data will be preserved in order to avoid any possibility of affecting the decisions made by the free will of the interested parties.
According to principal researcher Fernando Polack, participation in this program has multiple consequences: “We have a very ambitious project, which, although it represents less than 20% of the global study, represents the largest site in this review. On the other hand, opens the door for a country to fight to change its place in the vaccine distribution queue where the most powerful countries on the planet want to be first. We are trying to contribute to improving the situation in our country ”.
The sample selected to participate in the trial is quite large. “What we want to do is provide a sample of AMBA that eventually also serves the authorities to have a representative view of what is happening. For this reason, through the ethics committee of HMC and ANMAT, we have processed a bond that opens the possibility to all citizens without distinction and also to the inhabitants of Argentina who are not Argentines. Today we have more than 25 thousand registered for 4,500 vacancies, so not everyone who signs up will be called“Said Polack.
“There are currently five studies underway around the world, involving up to 100 research centers, testing different strategies to try to contain this problem that bothers us. AND One of these projects arrived at the Military Hospital to be evaluated by our team of researchers and to try to see if we can end this situation before the end of the year.“Polack emphasized.
The companies indicated that if the other tests are successful and the vaccine receives approval from the supervisory bodies, they intend to manufacture up to 100 million doses in the remainder of the year and potentially more than 1,200 million during 2021.
I keep reading
Argentina was selected to test Pfizer coronavirus vaccine
COVID-19: what the Argentine vaccine development process will be like at the Hospital Militar Central
When will the COVID-19 vaccine be ready? Two scientists working on the world’s most advanced projects answer the question